MYO TECHNOLOGY
Live / Allowed — Notice of allowance issued (as of 04 Nov 2025)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 30 Dec 2024 filing date already counts against anyone who files later.
Record
- Serial number
- 98927863
- Mark type
- Design + words
- Filed
- 30 Dec 2024
- Published for opposition
- 09 Sept 2025
- Attorney of record
- Brian P. O'Donnell
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations containing nucleic acid sequences that encode monoclonal antibodies for the treatment of cancer, autoimmune diseases, rare diseases, infectious diseases, inflammatory diseases, and blood disorders; Pharmaceutical compositions for the prevention and treatment of cancer, autoimmune diseases, rare diseases, infectious diseases, inflammatory diseases, and blood disorders; Nucleic acid sequences for medical purposes; Pharmaceutical compositions, namely, a nucleotide sequence that encodes an antigen, such as a DNA plasmid having an antigen encoding sequence and like DNA, for the prevention and treatment of cancer, autoimmune diseases, rare diseases, infectious diseases, inflammatory diseases, and blood disorders; Pharmaceutical preparations for human use for the treatment and prevention of cancer, autoimmune diseases, rare diseases, infectious diseases, inflammatory diseases, and blood disorders; pharmaceutical preparations for human and veterinary use, namely, antibiotics, antifungals and anti-virals; Gene therapy and prophylactic products, namely, gene delivery pharmaceuticals for the treatment of genetic or cell based conditions.
Owner
- RENBIO, INC., Long Island City, NY, US
- RENBIO, INC., Long Island City, NY, US
Prosecution history
- 04 Nov 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 09 Sept 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 09 Sept 2025 — PUBLISHED FOR OPPOSITION
- 03 Sept 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 11 Aug 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 06 Aug 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 06 Aug 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 06 Aug 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 22 Jul 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 22 Jul 2025 — NON-FINAL ACTION E-MAILED
- 22 Jul 2025 — NON-FINAL ACTION WRITTEN
- 11 Jun 2025 — ASSIGNED TO EXAMINER
- 02 Jun 2025 — NOTICE OF DESIGN SEARCH CODE E-MAILED
- 02 Jun 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 30 Dec 2024 — NEW APPLICATION ENTERED